Valued at USD 29.5 billion in 2024, the botanical supplements market is projected to reach USD 32.13 billion in 2025 and USD 69.4 billion by 2034, growing at a CAGR of 8.90% during the forecast period 2025–2034. Botanical supplements are products made from plants, plant parts, or plant extracts intended to supplement the diet and maintain or improve health. Growth is underpinned by a preference for herbal and natural health solutions, and North America was the largest regional market in 2024. Wider acceptance of herbal supplements across demographics is also giving manufacturers an opportunity to launch new products. Key players include Amway Corporation, BASF SE, Blackmores Limited, Botanicalife International of America, Inc., Dabur, GNC Holdings Inc., Himalaya Wellness, Nature's Bounty Co., Nutraceutical International Company, and P&G Health.
Research and Extraction Advances Strengthen the Botanical Supplements Market
Increased funding and research and development initiatives are supporting advancements in extraction technologies, quality control methods, and formulation techniques. The result is higher-quality products with standardized doses and improved bioavailability, which is propelling innovation in the botanical supplements market.
In April 2024, New CARBON released funding opportunities to improve understanding of the bioavailability, action, and optimal use of botanical supplements, in collaboration with the National Center for Complementary and Integrative Health and the NIH Office of Dietary Supplements. For manufacturers, progress in handling plant extracts is central to product differentiation. BASF SE, for example, partnered with Mazza Innovation to develop an environmentally friendly plant extraction process for cosmetic applications using PhytoClean technology.
Browse insights:
https://www.polarismarketresearch.com/industry-analysis/botanical-supplements-market
Rising Consumer Spending Fuels Botanical Supplements Demand
Rising spending power, health consciousness, and a preference for natural products are lifting demand. Consumers are choosing these products more frequently because of their enhanced therapeutic properties compared with traditional pharmaceuticals, which may have side effects.
According to the American Botanical Council's 2020 Herb Market Report, US botanical supplement sales exceeded USD 10 billion in 2020. Consumers invested USD 11.261 billion, a 17.3% surge and more than double the previous year's growth rate. These figures show how firmly herbal supplements have taken hold with US buyers.
Tablets Lead Form Segmentation
By form, the market is segmented into powder, liquid, tablets, capsules, gummies, and others. Tablets dominated in 2023, owing to consumer preference for convenience, ease of consumption, and availability in different dosage sizes. Increased pharmaceutical-sector R&D has also raised demand for tablets.
Demand for botanical tablets is illustrated by Kunnath Pharmaceuticals' November 2020 launch of Viromune, an antiviral immunity booster tablet containing a blend of 17 potent herbs. Format innovation extends further: in August 2023, Himalaya Wellness introduced Ashwagandha Organic Gummies containing clinically researched KSM-66 Ashwagandha root extract.
Regional Insights: North America Leads, Asia-Pacific Grows Fastest
North America dominated in 2024, with consumers aware of the preventive health and immunity-boosting properties of botanical products. According to the US National Institutes of Health, 20% of American adults use botanical supplements to manage health risks. Consumers are recognizing the benefits of ingredients such as curcumin, fenugreek, ashwagandha, and quercetin to enhance immunity. The American Botanical Council's 2021 Herb Market Report recorded triple-digit sales growth for ashwagandha and quercetin, with total sales of USD 12.35 billion for the year.
Europe accounted for a significant share. Asia-Pacific is expected to grow at the fastest CAGR, driven by strong preference for herb products in India, China, and Japan and the region's role as a major hub for herb production and exportation. India exported herbs worth USD 330.18 million in 2017–18, up 14.22%.
Competitive Strategies Among Market Leaders
Leading botanical supplements companies are investing heavily in R&D to expand product lines, alongside launches, contractual agreements, mergers and acquisitions, and collaborations. Manufacturing locally to minimize operational costs is a key tactic. Himalaya Wellness offers over 500 scientifically validated herbal products and operates in over 100 countries. The report also identifies regulatory challenges as a restraint, making quality and compliance important considerations for B2B buyers and suppliers.
More Trending Latest Reports By Polaris Market Research:
customer-success-management-market
non-invasive-cancer-diagnostics-market
military-simulation-and-virtual-training-market
viral-vector-and-plasmid-dna-manufacturing-market